Home/Pipeline/Novel CNS Programs

Novel CNS Programs

Treatment-resistant depression, cognitive disorders

Preclinical/Phase IActiveN/A

Key Facts

Indication
Treatment-resistant depression, cognitive disorders
Phase
Preclinical/Phase I
Status
Active
Company

About Otsuka Holdings

Otsuka Holdings is a multinational healthcare leader founded on the mission 'Otsuka-people creating new products for better health worldwide.' It has achieved global prominence through flagship CNS drugs, a strategic stake in Lundbeck, and blockbuster nutraceutical brands like Pocari Sweat. The company's strategy is built on a diversified four-pillar business model—pharmaceuticals, nutraceuticals, medical devices, and chemicals—driven by a unique culture of creativity ('Souzoususei') and evidence-based validation ('Jisshou').

View full company profile